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Posttranslational modification of proteins by the small molecule ubiquitin is a key regula-
tory event, and the enzymes catalyzing these modifications have been the focus of many 
studies. Deubiquitinating enzymes, which mediate the removal and processing of ubiquitin, 
may be functionally as important but are less well understood. Here, we present an inventory 
of the deubiquitinating enzymes encoded in the human genome. In addition, we review the 
literature concerning these enzymes, with particular emphasis on their function, specificity, 
and the regulation of their activity.Introduction
Over the last few decades, protein modification by ubiq-
uitin (Ub) and ubiquitin-like (Ubl) molecules has emerged 
as a critical regulatory process in virtually all aspects of 
cell biology. Indeed, the 2004 Nobel Prize in Physiology or 
Medicine was awarded for the discovery of Ub-mediated 
proteolysis.
More than a dozen different Ub and Ubl modifications 
have been described, and up to 20% of yeast proteins are 
conjugated to Ub under standard culture conditions (Peng 
et al., 2003; Welchman et al., 2005). In yeast, potentially all 
seven conserved lysines of Ub itself (K6, 11, 27, 29, 33, 48, 
and 63) are used as branching sites for the generation of 
Ub polymers.
The topic of ubiquitination, the proteins involved, and 
their functions in various pathways and signaling networks 
has been well reviewed (see Hershko and Ciechanover 
[1998]; Pickart and Eddins [2004]). Here, we discuss the 
enzymes that remove Ub from polypeptides. These deu-
biquitinating enzymes (DUBs) play key regulatory roles in 
a multitude of processes from hereditary cancer to neuro-
degeneration. Despite the importance of DUBs, our knowl-
edge of their mode of regulation and substrate specificity is 
surprisingly scant. A detailed annotation of individual family 
members of this enzyme group is an important step toward 
elucidating the molecular functions of DUBs in health and 
disease. To this end, we provide a comprehensive over-
view of putative DUBs encoded in the human genome. In 
addition, we discuss the lacunae in our understanding of 
these enzymes by drawing on examples from yeast and 
higher eukaryotes.
In our attempt to classify these enzymes, we have made 
some arbitrary decisions as to which genes to include or 
exclude as potential DUBs. Therefore, we present three 
caveats to this list. First, we cannot exclude the fact that proteins or protein families not included in this overview 
can remove Ub from polypeptides. For instance, a recent 
in silico effort to predict new Ub signaling components 
suggested a previously undetected family of Ub pepti-
dases (Iyer et al., 2004). Second, protein domain predic-
tion based on gene transcripts depends on consensus 
sequences. Thus, divergent but true family members can 
be missed due to low homology scores. Finally, we wish 
to emphasize that it is unlikely that all predicted DUBs are 
truly specific for Ub: some will display additional activity or 
exclusive activity toward Ubl molecules.
DUBs Are Proteases
DUBs belong to the superfamily of proteases, of which an 
estimated 561 members are present in the human genome 
(Puente and Lopez-Otin, 2004). Based on the mechanism 
of catalysis, proteases are divided into five classes—aspar-
tic, metallo, serine, threonine, and cysteine proteases—and 
further subdivided based on phylogeny.
Two classes of proteases (cysteine and metallo) con-
tain DUBs, although most DUBs are cysteine proteases. 
By definition, the enzymatic activity of cysteine proteases 
relies on the thiol group of a cysteine in the active site. 
Deprotonation of this cysteine is assisted by an adjacent 
histidine, which is polarized by an aspartate residue. These 
three residues make up the catalytic triad. During catalysis, 
the cysteine performs a nucleophilic attack on the carbonyl 
of the scissile peptide bond, which, in the case of DUBs, 
is between the target and Ub. The intermediate, which 
contains an oxyanion, is stabilized in the so-called oxy-
anion hole. This oxyanion hole is generally provided by a 
glutamine, glutamate, or asparagine residue and the main 
chain of the catalytic cysteine. The result of the reaction is 
release of the target protein and formation of a covalent 
intermediate with the Ub moiety. Reaction of this intermedi-Cell 123, December 2, 2005 ©2005 Elsevier Inc. 773
Figure 1. Structures of the Catalytic Domains of the Five Subclasses of Ub-Specific Proteases (Yellow) with Ub (Blue)
Structures show the remarkable variability in secondary structure between the DUB classes. Catalytic centers are shown as Van der Waals spheres 
(carbon, gray; nitrogen, blue; oxygen, red; sulfur, orange; zinc, purple) and have been aligned for easy comparison. The OTU domain of OTU2 lacks the 
conserved Asp in the catalytic center and the Asn/Glu/Gln that is normally used to stabilize the oxyanion hole in these proteases. For detailed structural 
information see Amerik and Hochstrasser (2004). Protein Databank (PDB) codes: USP7, 1nbf; UCH-L3, 1xd3; OTU2,1tff; Ataxin-3, 1yzb; JAMM, 1r5x.ate with a water molecule results in the release of the free 
enzyme and Ub.
In contrast to cysteine proteases, metalloproteases gen-
erally use a Zn2+ bound polarized water molecule to gen-
erate a noncovalent intermediate with the substrate. The 
metal atom is primarily stabilized by an aspartate and two 
histidine residues (Ambroggio et al., 2004). The intermedi-
ate is further broken down by proton transfer from a water 
molecule causing the release of the DUB.
The Human DUB Genes
The cysteine protease DUBs can be further organized into 
four subclasses based on their Ub-protease domains: 
ubiquitin-specific protease (USP), ubiquitin C-terminal 
hydrolase (UCH), Otubain protease (OTU), and Machado-
Joseph disease protease (MJD). All DUBs that are metallo-
proteases have a Ub protease domain called JAMM (JAB1/
MPN/Mov34 metalloenzyme). The structures of the cata-
lytic domains of the different subclasses of DUBs reveal an 
impressive diversity in secondary structure (Figure 1).
We used the ENSEMBL human genome database (v32, 
July 2005) to retrieve all putative DUBs from the human 
genome by selecting genes whose transcripts encode 
one of the five Ub protease domains. Our search identi-
fied all known DUBs except two DUBs with OTU domains 
(Otubain-1 and Otubain-2). This analysis indicated that the 
human genome encodes approximately 95 putative DUBs, 
including many that have not been previously reported. 
These can be broken down into 58 USP, 4 UCH, 5 MJD, 
14 OTU, and 14 JAMM domain-containing genes, many of 
which are associated with multiple transcripts (see Table S1 
in the Supplemental Data available with this article online). 
For six unnamed genes, we have submitted gene names 
to the HUGO gene nomenclature committee (HGNC) 
(Table  S1). To determine whether the putative DUB genes 
are expressed, we searched NCBI human-expressed 
sequence tag (EST) databases for transcripts correspond-
ing to the predicted protein sequence. We obtained further 
evidence for expression of a number of genes with rela-
tively low numbers of ESTs from additional sources (such 
as SAGE and UniGene). For five predicted DUBs, we could 
not find any convincing data supporting transcription.
Next, we generated sequence alignments to ensure 774 Cell 123, December 2, 2005 ©2005 Elsevier Inc.conservation of the catalytic residues and made an inven-
tory of DUBs reported to display Ub protease activity. This 
indicated that of the 90 putative DUBs that are expressed, 
11 are unlikely to display Ub-protease activity. Together, 
these data indicate that humans express approximately 79 
putative DUBs that are functional (Table S1).
To investigate sequence homology between the vari-
ous putative DUBs, we used two strategies. We used 
CLANS (Cluster analysis of sequences) software to visu-
alize pairwise all-against-all sequence BLAST matches 
(Frickey and Lupas, 2004). As expected, very few positive 
BLAST results were found between the five subclasses, 
whereas the members within the subclasses clustered 
together (Figure 2A). This analysis revealed that within the 
subclasses some relatively divergent members are pres-
ent (for example, Otubain-1 and Otubain-2, USP55, and 
CYLD). Similar results were obtained using the CLUSTAL 
alignment algorithm (Figure 2B).
The Five DUB Subclasses
Three-dimensional structures of DUB catalytic domains 
from all subclasses, some of them in complex with Ub 
derivatives, have been solved (Figure 1). These studies 
reveal intriguing similarities and differences between the 
four cysteine protease subclasses. This topic, including 
the structure of a JAMM domain, has recently been exten-
sively reviewed by Amerik and Hochstrasser (2004). Here, 
we comment on the new structural features of the DUB 
subclasses.
Ubiquitin C-Terminal Hydrolases (UCHs)
The human UCH subclass of DUBs consists of four pro-
teins that share close homology in their catalytic domains. 
Structural and biochemical studies have indicated that the 
UCH subclass of DUBs prefers to cleave relatively small 
protein substrates (up to 20–30 amino acids) from Ub 
(Amerik and Hochstrasser, 2004). This size limit is thought 
to be imposed by a loop that partially occludes the active 
site of these enzymes. However, recent biochemical and 
structural studies show that certain large substrates can 
nevertheless be accommodated (Misaghi et al., 2005).
Although UCHs were the first described DUBs, their 
specific functions remain poorly understood. UCHs are 
thought to mainly act in the recycling of Ub when Ub is 
inappropriately conjugated to intracellular nucleophiles 
(for example, glutathione, polyamines). They also may be 
involved in the processing of newly synthesized Ub, which 
is translated either as a polyubiquitin precursor or fused to 
ribosomal protein precursors. However, other DUBs also 
display in vitro activity toward linear Ub fusions, suggesting 
that processing of newly synthesized Ub 
is performed by multiple DUBs.
Some studies suggest a role for UCHs 
in specific Ub-regulated processes. 
Mutations in UCH-L1 (a UCH specifically 
expressed in neurons) that reduce its 
DUB activity have been described in two 
siblings with Parkinson’s disease (PD), 
and a polymorphism in this gene has 
been linked to reduced PD risk (Leroy et 
al., 1998; Liu et al., 2002). However, not 
all studies have found a strict relation-
ship between UCH-L1 activity and PD. 
Furthermore, although mice that have 
a mutation in Uch-L1 exhibit neurode-
generation, they do not display PD-like 
symptoms (Saigoh et al., 1999).
Ubiquitin-Specific Proteases (USPs)
The USP subclass represents the bulk 
of the DUBs encoded by the human 
genome. As the number of Ub E3 ligases 
(the third factor in the ubiquitination cas-
cade that determines target specificity) 
increased during evolution, so did the 
number of USPs, suggesting an intimate 
relationship between the two resulting in 
their coevolution (Semple, 2003).
The catalytic domain of USPs contains two short and 
well-conserved motifs, called Cys and His boxes, which 
include the residues critical for catalysis. However, the size 
of the complete domain varies from approximately 300 to 
800 amino acids due to the large unrelated sequences that 
Figure 2. Phylogenetic Map of Human 
DUBs
(A) Graphic two-dimensional representation of 
sequence similarities between all Ub protease 
domains of DUBs using CLANS software. CLANS 
performs all-against-all BLAST searches and uses 
the significant high-scoring segment pairs (HSPs) 
to draw a three-dimensional graph represented 
here in two dimensions. Each node represents a 
Ub protease domain and each edge (line) repre-
sents a significant HSP (edges are shaded accord-
ing to p value). DUB subclasses are highlighted in 
the graph. The start and end positions of the DUB 
Ub-protease domains, as defined by Interpro, were 
used to generate the protein sequences. Proteins 
with a partial or short and misaligning DUB domain 
were excluded from the analysis. 
(B) Unrooted dendrogram of the DUBs using 
Clustal software. Clustal generates a multiple 
sequence alignment file based on pairwise align-
ments. From this information a phylogenetic tree 
can be constructed. The robustness of the phylo-
genetic relations can be assessed by “bootstrap-
ping,” a mathematical technique that introduces 
noise in the alignment and measures how often 
the phylogenetic relationships reproduce. An as-
terisk indicates a bootstrapping percentage <10% 
(lowest branch only). The numbers correspond to 
the genes in Table S1.Cell 123, December 2, 2005 ©2005 Elsevier Inc. 775
Table 1. Mammalian DUBs and Their Reported Functions
Name Substrate(s) Process Remarks References
UCHs
UCH-L1 Unknown Parkinson’s disease Homodimer has E3 activ-
ity; mutant mice display 
ataxia
Leroy et al. (1998); Liu et al. (2002); 
Saigoh et al. (1999)
BAP1 Unknown Unknown Binds to BRCA1 Jensen et al. (1998)
UCH-L5 Unknown Ubiquitin editing,
TGF-β signaling?
Binds to proteasome Lam et al. (1997); Wicks et al. (2005)
USPs
CYLD TRAF2/6, NEMO NF-κB and JNK signaling Familial tumor suppressor 
(cylindromatosis) 
Brummelkamp et al. (2003); Kovalenko et 
al. (2003); Trompouki et al. (2003); Reiley 
et al. (2004)
USP1 FANCD2 DNA repair Nijman et al. (2005)
USP2 Fatty acid syn-
thase
Androgen signaling Circadian-regulated Graner et al. (2004); Oishi et al. (2003)
USP4 Unknown Unknown Transforming activity Gupta et al. (1994)
USP5 Unknown Unknown Binds K29 chains, binds 
ISG15 and Ub
Hemelaar et al. (2004); Russell and 
Wilkinson (2004)
USP6 Unknown Putative oncogene, actin 
remodeling
Transforming activity; re-
arrangements and fusions 
found in cancer
Masuda-Robens et al. (2003); Oliveira et 
al. (2005); Paulding et al. (2003)
USP7 HDM2, p53, H2B p53 signaling, Polycomb 
silencing
Binds herpes virus protein 
Vmw110
Cummins et al. (2004); Everett et al. 
(1997); Li et al. (2004); van der Knaap et 
al. (2005)
USP8 NRDP1 Endocytosis Oncogenic fusion with 
p85-PI3K 
Janssen et al. (1998); Kato et al. (2000); 
Wu et al. (2004)
USP9X β-catenin, ep-
sins, AF-6
Wnt-, Notch signaling, endo-
cytosis 
Murray et al. (2004); Overstreet et al. 
(2004)
USP9Y Unknown Spermatogenesis Mutants associated with 
azoospermia 
Sun et al. (1999)
USP11 BRCA2 DNA repair? Interacts with RanBPM Ideguchi et al. (2002); Schoenfeld et al. 
(2004)
USP14 Unknown Synapse function Mutant mice develop 
ataxia; binds to protea-
some
Borodovsky et al. (2001); Wilson et al. 
(2002)
USP15 RBX1 COP9 signalosome Hetfeld et al. (2005)
USP16 H2A? Chromosome condensation? Mimnaugh et al. (2001)
USP18 Unknown JAK-STAT signaling, immu-
nity, brain function
ISG15-specific; mRNA 
is induced by IFN-α and 
IFN-β
Malakhova et al. (2003); Ritchie et al. 
(2004); Ritchie et al. (2002)
USP20 DIO2? Thyroid hormone metabolism, 
hypoxia signaling
Interacts with pVHL Curcio-Morelli et al. (2003); Li et al. 
(2002b)
USP21 Unknown Unknown Cleaves Ub and NEDD8 
but not SUMO
Gong et al. (2000)
USP26 Unknown Spermatogenesis mUsp26 is testis specific Paduch et al. (2005); Stouffs et al. (2005); 
Wang et al. (2001)
USP33 HIF1-α DIO2? Hypoxia signaling Interacts with pVHL Curcio-Morelli et al. (2003); Li et al. 
(2002b); Li et al. (2005)776 Cell 123, December 2, 2005 ©2005 Elsevier Inc.
MJDs
Ataxin-3 Unknown MJD disease Sequence has CAG 
repeats
Burnett et al. (2003); Scheel et al. (2003)
OTUs
A20 RIP NF-κB signaling Also E3 ligase Wertz et al. (2004)
VCIP135 Unknown Golgi disassembly Wang et al. (2004)
JAMMs
POH1 Unknown Proteasome Verma et al. (2002); Yao and Cohen 
(2002)
AMSH EGFR? Endocytosis McCullough et al. (2004)
CSN5 Cullins CSN function Mainly NEDD8 as sub-
strate
Cope et al. (2002); Groisman et al. (2003)
BRCC36 Unknown G2/M checkpoint signaling Enhances BRCA1/BARD1 
E3 ligase activity
Dong et al. (2003)
Listed are DUBs that have been linked to specific pathways, processes, and substrates (based on published studies).
Table 1. Mammalian DUBs and Their Reported Functions (continued)are interspersed between the two motifs, which may serve 
a regulatory function (Figure 3).
Upon closer examination of the catalytic domains of 
USPs, we noted that a subset (USP16, USP30, USP39, 
USP45, and USP52) lack catalytic residues previously 
thought to be critical for protease activity (Figure S1). 
USP30 and USP16 lack only the aspartate in the catalytic 
triad but retain enzymatic activity against a model sub-
strate (Table S1 and M.P.A.L.-V. and T.K.S., unpublished 
data). This indicates that, as is the case for the Otubain-2 
protein, USP30 and USP16 may use a different residue to 
stabilize the active site histidine. Additional structural infor-
mation about USPs may shed light on this issue.
USP39 (also known as SAD1) does not contain the con-
served catalytic cysteine or histidine and does not cleave 
a model substrate in vitro, indicating that USP39 is not a 
bona fide DUB (M.P.A.L.-V. and T.K.S., unpublished data). 
However, USP39 plays a critical role in spliceosome mat-
uration in both yeast and human cells, and many of the 
other residues within the catalytic domain are conserved 
(Lygerou et al., 1999; Makarova et al., 2001). Therefore, it 
is tempting to speculate that USP39 can still interact with 
Ub. An analogous situation exists in Ub conjugation. Here, 
a Ub interaction motif known as UEV (ubiquitin-conjugating 
enzyme variant) strongly resembles the catalytic domain 
of E2s (the second enzyme in the ubiquitination cascade) 
but lacks activity (Hicke et al., 2005). In keeping with this 
nomenclature, these catalytically inactive USP domains 
are hereby referred to as USPV (ubiquitin-specific protease 
variant). The functions of these variants with respect to Ub 
await further investigation.
Machado-Joseph Disease Protein Domain Prote-
ases (MJDs)
A bioinformatics search for other classes of Ub proteases 
identified Ataxin-3 and a number of Ataxin-3-like proteins 
(Scheel et al., 2003). Experiments in vitro confirmed that wild-type Ataxin-3, but not a mutant with the active site 
cysteine mutated, could deubiquitinate a model substrate 
(Burnett et al., 2003). Sequence similarity between the 
catalytic domain of Ataxin-3 and other DUBs is low (Fig-
ure 2A), but recent NMR structures show that the overall 
arrangement of the catalytic triad is conserved (Figure 1; 
Mao et al., 2005; Nicastro et al., 2005).
Instability of a CAG nucleotide repeat in the Ataxin-3 
gene leads to a hereditary neurological condition known 
as spinocerebellar ataxia type-3 or Machado-Joseph dis-
ease (OMIM 607047). Like other polyglutamine neurode-
generative disease-associated genes, expansion of the 
CAG repeat in Ataxin-3 leads to protein misfolding, result-
ing in aggregation and cellular toxicity. Some experimen-
tal evidence indicates that the normal function of Ataxin-
3 involves transcriptional regulation, but whether its DUB 
activity plays a role in this process remains unclear (Li et 
al., 2002a). In evolutionary terms, MJDs likely represent a 
relatively late addition to the Ub system, as no homologs 
have been identified in yeast. However, protease activity of 
the other family members has not yet been demonstrated, 
and their biological functions remain unknown.
Ovarian Tumor Proteases (OTUs)
A bioinformatics approach also led to the identification 
of the Ovarian Tumor (OTU) subclass of Ub proteases 
(Makarova et al., 2000). The otu gene is involved in the 
development of the Drosophila melanogaster ovary where it 
may regulate the localization and translation of certain RNA 
transcripts (Goodrich et al., 2004; Steinhauer et al., 1989). 
Using the Drosophila otu gene and its homologs as a start-
ing point, Makarova and colleagues (2000) found sequence 
similarity between these genes and those encoding viral 
cysteine proteases. A recently solved OTU structure shows 
that, unlike other cysteine protease DUBs, the catalytic triad 
is incomplete and is stabilized by a new method involving a 
hydrogen bonding network (Nanao et al., 2004).Cell 123, December 2, 2005 ©2005 Elsevier Inc. 777
Figure 3. Comparison of the Domain Structures of Putative DUBs 
For each primary DUB transcript (the transcript associated with the HUGO or RefSeq ID), we retrieved information concerning domain architecture and 
signal motifs using ENSEMBL, SMART (simple modular architecture research tool; http://smart.embl-heidelberg.de/), Pfam (protein families database; 
 http://www.sanger.ac.uk/Software/Pfam/), and PROSITE databases. The USPs without additional domains are indicated as “generic USP.” Only JAMM 
and MJD domain proteins with predicted catalytic activity are shown. An asterisk indicates that the ENSEMBL-predicted translational start site is uncertain. 
Proteins and domains are plotted on an approximate scale. Select abbreviations: ZnF, zinc finger; NLS_BP, bipartite nuclear localization signal; MATH, 
meprin and TRAF homology; DUSP, domain in ubiquitin-specific proteases. For additional information concerning the indicated domains visit http://www.
ebi.ac.uk/interpro/.778 Cell 123, December 2, 2005 ©2005 Elsevier Inc.
Otubain-1 and Otubain-2 were the first two OTU pro-
teins found to display in vitro DUB activity (Balakirev et al., 
2003). Shortly thereafter, Cezanne, another OTU-domain 
containing protein, was found to interact with poly-Ub in 
a yeast two-hybrid assay and to contain DUB activity in 
vitro, suggesting that this is a general OTU feature (Evans 
et al., 2003). However, for most OTU proteases, their phys-
iological role in vivo, including their putative role as DUBs, 
remains to be investigated.
JAMM Motif Proteases
The JAMM domain is found in all three major kingdoms of 
life (bacteria, archaea, and eukarya). However, bacteria do 
not contain Ub protease activity, and an analogous Ub-like 
conjugation system has not yet been identified in prokary-
otes. This suggests that JAMM domains have adopted new 
protease functions during evolution and indicates that at 
least some of the human JAMM proteases may be involved 
in more than Ub (or Ubl) processing. Indeed, recent work 
has identified the protein product of the Mycobacterium 
tuberculosis gene mec+ as a JAMM domain peptidase 
involved in cysteine biosynthesis by cleaving cysteine from 
a peptide intermediate (Burns et al., 2005).
Sequence alignment of the JAMM-domain proteins 
revealed that seven of the 14 members have at least one 
amino acid change in the conserved Zn2+ ion-stabilizing 
residues, indicating that they may not be functional pro-
teases. Three family members (POH1, CSN5, and AMSH) 
will be briefly discussed in the section concerning DUB 
function.
DUB Specificity
Accumulating evidence indicates that most DUBs regu-
late a limited number of proteins and pathways, suggest-
ing that they target specific substrates (Table 1). In the 
case of DUBs, specificity can refer to either the Ub or Ubl 
moiety itself (substrate specificity) or the target protein 
to which the moiety is conjugated (target specificity). In 
reality, it may not be possible to separate these types of 
specificities. It is likely that in many cases a combinatorial 
mechanism relying on recognition of both the target and 
the attached moiety determines overall DUB specificity. 
Additional mechanisms, such as protein localization and 
interactions with binding partners, may further contribute 
to in vivo specificity. In the following sections, we will dis-
cuss current insights into DUB specificity.
Substrate Specificity: Ubiquitin Polymers
Protein ubiquitination comes in many different flavors that 
serve distinct functions (Welchman et al., 2005). Whereas 
poly-Ub chains linked through the lysine residues of Ub at 
position 48 (K48) target proteins for proteasomal degra-
dation, the attachment of a single Ub moiety (monoubiq-
uitination) appears to regulate subcellular localization and 
recruitment of Ub binding proteins. Besides mono- and 
K48-linked polyubiquitination, other poly-Ub branches 
using alternative lysines on Ub have been described. 
The relevance and function of most of these different 
types of polymers is currently unknown, but future stud-
ies may reveal unique regulatory roles. A notable excep-tion is K63 polyubiquitination, which has been described 
for a number of mammalian proteins, including RIP, NEMO 
and TRAFs (Sun and Chen, 2004). These signaling mol-
ecules are involved in activation of NF-κB signaling, a path-
way involved in inflammation, apoptosis, and tumorigen-
esis. As in the case of mono-Ub, K63 polyubiquitination 
is required for the activation of downstream molecules, 
like kinases, or recruitment of other proteins. K63-linked 
Ub molecules differ remarkably from K48 chains in their 
three-dimensional structure, which probably accounts for 
their distinct functions (Varadan et al., 2004). Furthermore, 
this suggests that certain DUBs may act on specific Ub 
branches. Indeed, the yeast DUB Ubp2 prefers K63 over 
K48-linked Ub chains as a substrate (Kee et al., 2005). 
Conversely, examples of DUBs cleaving K48 but not K63-
linked Ub polymers include USP8 and USP14 (Hu et al., 
2005; McCullough et al., 2004). Another DUB, UCH-L5 
can cleave various types of branches but does not display 
activity toward linear Ub dimers. Other examples further 
support the notion that DUBs cleave poly-Ub variants with 
varying efficiency, at least in vivo. One such example is the 
protein product of the Cylindromatosis tumor-suppressor 
gene (CYLD), a DUB involved in inhibiting NF-κB signal-
ing (Brummelkamp et al., 2003; Kovalenko et al., 2003; 
Trompouki et al., 2003). CYLD cleaves linear Ub fusions 
in vitro; yet in vivo it appears to be specific for non-K48-
linked Ub chains. The basis for the specificity observed in 
vivo remains unclear, but phylogenetic analysis indicates 
that the catalytic domain of CYLD is relatively divergent 
from other DUBs, as indicated by its unique protease fam-
ily identifier, C67 (Table S1 and Figure 2). This information 
leads us to speculate that the architecture of the enzymatic 
cleft contributes to its specificity. The OTU-type DUB A20 
is another potent inhibitor of NF-κB signaling (Wertz et al., 
2004). In vitro, A20 can cleave both K48- and K63-linked 
Ub polymers with similar efficiency. Yet in vivo, A20 deu-
biquitinates K63 but not K48 polyubiquitinated RIP (the 
protein we mentioned previously that is involved in NF-κB 
activation). However, given that A20 also contains (K48) 
E3 ligase activity toward RIP, it is not clear if the apparent 
K63 DUB activity in vivo is due to true substrate preference 
or simply due to its ability to catalyze the addition of K48-
linked Ub polymers.
In at least some cases, domains outside the catalytic 
domain may contribute to Ub chain specificity (Lin et al., 
2001). Splice variants of USP2 and a mutant containing only 
the core catalytic domain of this DUB cleave both linear Ub 
fusions and K48-linked Ub polymers. However, their rela-
tive efficiency varies considerably. The core domain prefers 
linear fusions, but full-length USP2b was most efficient in 
cleaving K48-linked Ub. Although USP2 does not contain 
an additional, known Ub-interaction motif, it is conceivable 
that sequences outside the catalytic domain contribute 
to selection and positioning of specific Ub chains. In fact, 
Ub-interaction motifs found in some E2 ligases have been 
implicated in determining linkage specificity. Indeed, it was 
recently described that a previously unnoticed Ub-interact-
ing Zinc finger domain in USP15 is needed for disassem-Cell 123, December 2, 2005 ©2005 Elsevier Inc. 779
Figure 4. DUB Specificity and Regulation
(A) DUB/E3 interactions. DUBs and E3 are often 
found in a complex together. These interactions, 
which occur between USP7 and HDM2, for ex-
ample, serve to reverse E3-mediated autoubiqui-
tination (left panel) or allow the E3 to regulate the 
target and its DUB simultaneously as in the case 
of USP20 and pVHL (middle panel). Alternatively, 
DUB/E3 interactions confer specificity to the DUB, 
as in the case of Ubp2 and Rsp5 (right panel). E3 
Ub-ligase and Ub-protease activity is indicated 
with black arrows and red arrows, respectively. Ub 
conjugated to E2 is not shown for clarity. 
(B) DUB activity is regulated at various levels, in-
cluding transcription (left panel), degradation, and 
binding to stimulatory or inhibitory cofactors (right 
panel). The exact mechanism whereby these co-
factors regulate DUB activity is unknown but may 
occur at multiple levels (for example, phosphory-
lation, subcellular localization), stimulating confor-
mational changes or conferring specificity.bling branched Ub polymers but not for cleavage of a linear 
Ub-GFP fusion (Hetfeld et al., 2005). Another recent study 
showed that addition of a UBA domain that recognizes 
K48-Ub chains to USP5 skewed its substrate preference 
toward this type of Ub polymer (Raasi et al., 2005). Simi-
larly, other Ub binding domains frequently encountered in 
DUBs, like UIM and ZnF-UBP (also called PAZ) may also 
contribute to Ub chain selection (Figure 3).
Substrate Specificity: Ubiquitin and Ubiquitin-like 
Molecules
The vast majority of putative DUBs tested so far display 
Ub protease activity in vitro (Table S1). Nonetheless, some 
predicted DUBs may be active toward Ubl moieties. There-
fore, when considering DUB specificity, we wish to extend 
our discussion to both Ub and Ubl moieties. USP21 and 
UCH-L3 cleave both Ub and the Ubl molecule NEDD8. 
USP18 has been proposed to specifically cleave another 
Ubl, ISG15 (Gong et al., 2000; Malakhov et al., 2002; Wada 
et al., 1998). Furthermore, although some circumstantial 
evidence indicates that CSN5 may contain Ub protease 
activity, its main proteolytic target is thought to be the Ubl 
NEDD8 (Groisman et al., 2003; Verma et al., 2002; Yao and 
Cohen, 2002). For other Ubl molecules, distinct proteases 
have been identified. For instance, newly synthesized Ubl 
Atg8 is processed by a distinct protease (Apg4) of which 
five family members are found in the genome (Kirisako et 
al., 2000). Likewise, protease activity toward SUMO (small 
ubiquitin-like modifier) has thus far been restricted to the 
SENP family of cysteine proteases, of which seven genes 
are present in the human genome. However, within this 
family proteolytic activity is not limited to SUMO; SENP8 
(also known as DEN1) is a NEDD8-specific protease (Gan-
Erdene et al., 2003; Wu et al., 2003).
Our current knowledge of the motifs or residues in these 
proteases that are responsible for distinguishing Ub from 
Ubl moieties is limited. Clearly, more in vitro and in vivo 
analysis of DUBs and Ubl proteases, including structural 
information, is required.780 Cell 123, December 2, 2005 ©2005 Elsevier Inc.Target Specificity and DUB/E3 Interactions
The recognition of targets by DUBs may be directed by 
sequences and motifs outside the conserved catalytic 
core. For instance, one of the Cap-Gly domains of CYLD 
mediates its interaction with NEMO, a potential CYLD sub-
strate (Figure 3; Saito et al., 2004). However, like most 
enzyme/substrate interactions, DUB/target interactions 
are expected to be weak and transient in nature, mak-
ing the identification of in vivo targets frustrating. A more 
stable complex between a DUB and its target may occur 
in the case when proteins are inappropriately K48 poly-
ubiquitinated (Figure 4A, left panel). These proteins need 
to be continuously deubiquitinated to protect them from 
unwanted degradation. Autoubiquitination by ring finger-
type E3 ligases is a frequently observed phenomenon 
resulting from nonspecific ubiquitination of proximal lysines 
(careless gunplay). For instance, the E3 ligase NRDP1 
stimulates its own turnover as well as a number of cellular 
targets. The DUB USP8 associates with NRDP1 resulting 
in its deubiquitination and stabilization, suggesting that 
interaction with a DUB may simply serve to antagonize 
this self-inflicted degradation (Wu et al., 2004). Similarly, 
the interaction of USP7 with HDM2 and USP15 with Rbx1 
results in the stabilization of these E3 ligases (Canning et 
al., 2004; Cummins et al., 2004; Hetfeld et al., 2005; Li et 
al., 2004). Interestingly, USP7 was also found to stabilize 
the herpes virus E3 ligase ICP0, indicating that viruses can 
hijack cellular DUBs to stabilize viral proteins. The impor-
tance for controlling Ub dynamics in the herpes virus life 
cycle is further underscored by the recent finding that the 
herpesviridae contains a distinct class of cysteine protease 
DUBs without known mammalian homologs (Kattenhorn 
et al., 2005).
Not all DUB/E3 interactions strictly serve to regulate E3 
ligase stability. The E3 tumor suppressor protein pVHL 
regulates the stability of HIF1 transcription factors that are 
important regulators of angiogenesis. USP33 interacts 
with this E3 (Li et al., 2002b) and appears to regulate HIF1 
stability by deubiquitination (Li et al., 2005). This suggests 
that, in this case, interaction of the DUB with the E3 allows 
the E3 ligase to differentially regulate the primary protea-
somal target (HIF1) as well as its deconjugating enzyme 
(Figure 4A, middle panel).
Kee and colleagues (2005) recently suggested a third 
type of DUB/E3 interaction. They postulated that in some 
cases the DUB may hitch along with the E3 ligase. They 
showed that the target specificity of the yeast DUB Ubp2 is 
strictly dependent on the E3 ligase Rsp5, which is respon-
sible for recognition of the substrate (Figure 4A, right panel). 
A remarkable variation on this theme is the previously men-
tioned protein A20. Here, E3 ligase and DUB activity reside 
in the same polypeptide (Wertz et al., 2004).
DUB Function
Gene deletion studies in yeast have indicated that none of 
the USPs are required for cell growth or viability (Amerik et 
al., 2000). Nonetheless, USPs and other DUBs in lower and 
higher eukaryotes including mammals have been implicated 
in regulating various critical cellular processes in a nonre-
dundant manner. Human DUBs (or their murine homologs) 
of particular interest that have been linked to defined cel-
lular processes or substrates are listed in Table 1.
The functions of DUBs at the proteasome lid, in endocy-
tosis and regulation of chromatin structure, are reasonably 
well understood and are therefore discussed in some detail 
in the following sections. In addition, we will propose some 
directions for future studies.
DUBs and Proteasome Function
Proteins that must undergo fast and dramatic changes 
in abundance are often regulated by proteolysis. These 
proteins are targeted to the proteasome by K48-linked 
polyubiquitination, where they are degraded. The 26S 
proteasome consists of two 19S regulatory particles and 
a 20S cylinder-shaped multiprotein complex possessing 
the proteolytic activity (Pickart and Cohen, 2004). The 19S 
subunit restricts access to the interior of the 13 Å cylinder 
of the proteasome, which is where the catalytic residues 
for proteolysis are located. Deubiquitination of proteins 
arriving at the proteasome allows recycling of Ub and is 
required for protein degradation. In fact, deubiquitination, 
protein unfolding, translocation into the proteasome, and 
degradation are intimately linked processes. A number of 
DUBs from various subclasses have been found in complex 
with the 19S proteasome regulatory component, including 
the JAMM protease POH1 (Rpn11 in yeast), UCH-L5, and 
USP14 (Ubp6 in yeast) (Borodovsky et al., 2001; Lam et al., 
1997; Park et al., 1997; Verma et al., 2002). Interestingly, 
residents of a paralogous multiprotein structure known as 
the COP9 signalosome are the JAMM protein CSN5 and 
USP15 (Cope et al., 2002; Zhou et al., 2003). Like the pro-
teasome, the COP9 signalosome has been implicated in 
a diverse array of biological processes. At least some of 
these functions can be explained by its ability to inhibit the 
activity of the cullin family of ubiquitin E3 ligases by CSN5-
mediated deneddylation.
The main DUB activity at the proteasome appears to be generated by POH1, since deletion of the gene that encodes 
this enzyme results in defective proteasomal degradation 
and is lethal in yeast. The functions of the other DUBs may 
be partially redundant with POH1, only playing a role in the 
deubiquitination of specific substrates, or in “Ub editing.” 
The Ub-editing concept was postulated as a mechanism 
to rescue proteins that have been mistakenly ubiquitinated 
(as recognized by having short Ub chains) from destruc-
tion. The suggested Ub-editing mechanism would remove 
Ub polymers, starting at the distal end, independently of 
the substrate moiety (Lam et al., 1997). Although UCH-L5 
indeed cleaves Ub chains from the distal end, compelling 
evidence for an Ub-editing function for UCH-L5 has not 
yet been provided, and no ortholog of UCH-L5 has been 
found in Saccharomyces cerevisiae.
DUBs and Chromatin Structure
An increasing body of evidence implicates dynamic histone 
ubiquitination in the regulation of transcription and silenc-
ing, and even double-strand-break formation during meio-
sis (Yamashita et al., 2004). Although most histone proteins 
can be ubiquitinated, the dynamics of H2B monoubiqui-
tination are best understood. In yeast, deubiquitination of 
H2B by the DUB Ubp10 is required for telomeric silencing. 
This in turn allows recruitment of the silencing factor Sir2. 
(Emre et al., 2005). Interestingly, a second USP Ubp8 has 
been implicated in regulating H2B. In contrast to Ubp10, 
deubiquitination of H2B by Ubp8 correlates with transcrip-
tional activation (Gardner et al., 2005; Henry et al., 2003). 
At least at some sites of active transcription, Ub-H2B levels 
are high during activation and subsequently decrease in 
an Ubp8-dependent manner. Importantly, both the ubiq-
uitination and deubiquitination of H2B are necessary for 
optimal transcription, indicating a requirement for dynamic 
H2B modification by Ub (Henry et al., 2003).
Similar to yeast Ubp10, Drosophila USP7 interacts prefer-
entially with silenced genomic regions, including telomeric 
domains, where it has been suggested to deubiquitinate 
H2B and thereby contribute to Polycomb-mediated silenc-
ing (van der Knaap et al., 2005). In mammals, USP7 asso-
ciates with HDM2, an E3 ligase critical for regulating p53 
turnover, and thereby inhibits degradation of both HDM2 
and p53 (Cummins et al., 2004; Li et al., 2004). Indeed, 
different levels of USP7 can have opposite outcomes with 
respect to p53 stability. Intermediate inhibition of USP7 
result in increased p53 degradation, whereas complete 
inhibition of USP7 enhances p53 stability. Interestingly, a 
recent report has suggested that HDM2 can mediate H2B 
ubiquitination (Minsky and Oren, 2004). Together, these 
data suggest an attractive model in which HDM2/p53/
USP7 complexes mediate transcriptional repression by 
regulating H2B ubiquitination.
DUBs and Endocytosis
Monoubiquitination and, at least in yeast, the attachment 
of a K63-linked Ub dimer, play an important role in endo-
cytosis of receptors and sorting of proteins (Haglund et 
al., 2003; Hicke and Dunn, 2003). After binding to ligands, 
receptor tyrosine kinases (RTKs) and adaptor proteins are 
monoubiquitinated at multiple sites, which triggers their Cell 123, December 2, 2005 ©2005 Elsevier Inc. 781
internalization. The RTKs are subsequently either recycled 
or transported to lysosomes for destruction. The E3 ligase 
for many RTKs is the protooncogene Cbl, which can also 
induce proteasome-dependent degradation by stimulating 
K48 polyubiquitination (Duan et al., 2004). Repeated addi-
tion of Ub or reduced deubiquitination may be the trigger 
for targeting to the lysosomal compartment, though exactly 
how ubiquitination determines this decision is unclear. 
Ub-interacting proteins like Hrs subsequently bind to the 
monoubiquitinated receptor and recruit protein complexes 
involved in budding of the endocytic vesicle.
DUBs are implicated in the endocytic pathway at mul-
tiple levels and also play important roles in other types of 
intracellular traffic. In yeast, the DUB Doa4 acts to recycle 
Ub at the late endosome to rescue Ub from destruction. 
Inactivation of Doa4 interferes with many Ub-related pro-
cesses since it results in depletion of free Ub and many of 
the defects observed on Doa4 mutant cells are restored 
upon expression of additional Ub (Swaminathan et al., 
1999). The closest human relative of Doa4 is USP8, which 
binds the Hrs binding partner (Hbp) and inhibits EGF 
receptor (EGFR) endocytosis, suggesting that USP8 may 
act to regulate endocytic traffic (Kato et al., 2000; Mizuno 
et al., 2005). Remarkably, a second Hrs interacting pro-
tein is AMSH, a JAMM domain DUB (McCullough et al., 
2004). Inhibition of AMSH results in the accumulation of 
endosomal Ub and promotes EGFR endocytosis thereby 
accelerating EGFR downregulation.
Yet more DUBs are implicated in controlling endocyto-
sis. In Drosophila, Fat facets (Faf; the homolog of human 
USP9X), deubiquitinates Liquid facets (Lqf), resulting in 
enhanced Lqf activity (Overstreet et al., 2004). Lqf and Faf 
play a role in Drosophila eye development by enhancing 
the internalization of a receptor implicated in cell pattern-
ing, called Delta. In humans, Lqf homologs are known as 
epsins, adaptor molecules involved in the initial steps of 
endocytosis.
Ubiquitination and deubiquitination appears to be a 
common theme in vesicle dynamics; monoubiquitination 
plays a critical role in budding of some viruses. Additionally, 
VCIP135, a OTU, has been implicated in Golgi assembly 
after mitosis (Wang et al., 2004).
Other Potential Roles for DUBs
Indications for the function of DUBs may come from vari-
ous sources, including genetic screens in model organ-
isms, interactome data, and domain- and signaling-motif 
predictions. Genetic screens in model organisms like the 
worm Caenorhabditis elegans and the fruit fly Drosophila 
are pointing at new roles for DUBs in various pathways. 
For instance, screens in C. elegans for modulators of RNA 
interference or longevity suggest an involvement of a USP 
and a UCH (Hamilton et al., 2005; Kim et al., 2005). In addi-
tion, a protein with both a USP and OTU domain (Duo-
2) has recently been implicated in synapse function (Sie-
burth et al., 2005). These studies further solidify the broad 
involvement of the Ub conjugation/deconjugation system 
in biological processes and will certainly spark research 
into the functions of the human DUB orthologs.782 Cell 123, December 2, 2005 ©2005 Elsevier Inc.Data derived from large-scale human protein-protein 
interaction experiments has implicated a number of USPs 
in several signaling cascades such as the TGF-β and 
NF-κB pathways. For instance, USP45 binds specifically 
to the phosphorylated TGF-β receptor in a mammalian 
two-hybrid (Barrios-Rodiles et al., 2005). Similarly, USP11 
and USP9 interact with the NF-κB transcription factors 
RelB and p100, respectively (Bouwmeester et al., 2004). 
Although the significance of these interactions remains to 
be determined, these findings suggest that DUBs may play 
a regulatory role in these pathways.
Hints to the function of DUBs may be obtained from 
additional domains and signal motifs present in the pri-
mary amino acid sequence of these enzymes (Figure 3). 
For instance, USP7 might be involved in specific signaling 
pathways as it contains a MATH (meprin and TRAF homol-
ogy) domain. These domains are found in members of 
the TRAF family of ring finger E3 ligases which mediates 
signaling via TNF receptors. Similarly, the JAMM2 protein 
might play a role in transcription and chromatin remodel-
ing, as it contains domains (SWIRM and Myb DNA binding 
motif) implicated in these processes.
Regulation of DUBs
In contrast to many proteases, such as caspases that are 
translated as inactive precursors, DUBs are generally pro-
duced as active enzymes. Structural analysis has pointed 
out that the catalytic triad of UCHs and USPs only assume 
the active confirmation when bound to Ub, thereby pre-
venting spurious protease activity against other substrates. 
In addition, various studies show that a diverse array of 
mechanisms regulates DUB activity and additional ones 
are likely to be discovered.
In the case of at least two JAMM domain proteins (POH1 
and CSN5), it appears that incorporation into higher-order 
protein structures (the 19S proteasome and COP9 signalo-
some, respectively) is required for peptidase activity (Cope 
et al., 2002; Verma et al., 2002). Similarly, accessibility of 
the enzymatic cleft of USP14 appears to be regulated by 
activity of the 26S proteasome, its resident complex (Boro-
dovsky et al., 2001).
Bre5, a cofactor for the yeast DUB Ubp3, is largely 
responsible for its in vivo activity toward Sec23, a protein 
involved in anterograde transport between the endoplas-
mic reticulum and the Golgi compartment (Cohen et al., 
2003). Bre5 does not bind directly to Sec23, suggesting 
that the interaction between Bre5 and Ubp3 regulates 
Ubp3 activity. Surprisingly, the human homolog of Bre5, 
G3BP1, inhibits the activity of USP10, at least in vitro, indi-
cating that cofactors can either restrict or enhance prote-
ase activity (Figure 4B, right panel; Soncini et al., 2001). A 
USP7 cofactor called GMPS that strongly augments USP7 
activity was recently identified in Drosophila (van der Knaap 
et al., 2005). In addition, USP7 is regulated during apop-
tosis by cleavage by caspases. This cleavage presumably 
inactivates USP7 (Vugmeyster et al., 2002).
DUBs have frequently been found to be degraded by 
the proteasome, indicating that their abundance is an 
important regulatory mechanism (Figure 4B, right panel). 
Moreover, some DUBs have been reported to be transcrip-
tionally regulated (Figure 4B, left panel), sometimes in a 
cell-cycle-regulated manner (for example, USP1) or as part 
of a negative feedback loop (such as CYLD; Jono et al., 
2004; Nijman et al., 2005).
In another case, inhibitory phosphorylation of CYLD 
after TNF-α stimulation is required for the accumulation of 
one of its proposed substrates, K63-ubiquitinated TRAF2. 
Interestingly, this event does not appear to modulate the 
affinity of CYLD for TRAF2, suggesting that phosphoryla-
tion may directly regulate CYLD activity by an unknown 
mechanism (Reiley et al., 2005).
Concluding Remarks
A large number of studies over the last decade have uncov-
ered an unanticipated diversity of protein regulation by Ub 
and Ubl molecules. Nature has utilized the versatility of 
Ub in almost any conceivable way. Strikingly, the ubiquitin 
conjugation/deconjugation system outcompetes the pro-
tein phosphorylation system in terms of diversity and com-
plexity. Although the reversal of ubiquitination by DUBs has 
been firmly established as a critical regulatory mechanism, 
we are only beginning to uncover the different mechanisms 
that control the activity of these enzymes.
Remarkably, the Ub E3 ligases greatly outnumber the 
DUBs encoded in the human genome. This is in contrast 
to tyrosine kinases and phosphatases, which are roughly 
equal in number. One possible explanation is that we have 
not yet identified all DUBs or their associated cofactors that 
may determine specificity. Indeed, Serine/Threonine kinases 
outnumber Serine/Threonine phosphatases, but a large 
variety of cofactors provide additional specificity to these 
phosphatases. It is also possible that many DUBs have poor 
substrate specificity and regulate on average up to 10 times 
more substrates than the average E3 ligase. However, most 
DUBs studied thus far appear to regulate a small number of 
targets. Another more likely explanation for the excess of E3 
ligases could be that only a fraction of the targets that are 
ubiquitinated are regulated by specific deubiquitination. For 
destruction mediated by K48 Ub polymers, we would pre-
dict that many proteins are not deubiquitinated prior to arrival 
at the proteasome. Unless of course when you have made 
a mistake, why recycle a protein that you have decided to 
throw away? Possibly, only proteins that require extremely 
tight regulation, such as p53, require additional regulation 
by deubiquitination. Indeed, other types of Ub-based modi-
fications, like K63-linked polymers or monoubiquitin require 
DUBs to “reset” the protein to its unmodified state and are 
thus more likely to be critically regulated by DUBs. Undoubt-
edly, future studies aided by detailed genomic annotation, 
structural information, and other new tools and methods 
to characterize this intriguing protein family will result in the 
demystification of these proteases.
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